Case report: Fatal mesenteric and retroperitoneal serositis after pelvic chemoradiation followed by a single dose of chemotherapy and nivolumab

Case report: Fatal mesenteric and retroperitoneal serositis after pelvic chemoradiation followed by a single dose of chemotherapy and nivolumab

We report a previously undescribed fatal toxicity in a 54 years old female patient suffering from a locally advanced adenocarcinoma of the rectum. She received standard neoadjuvant chemoradiotherapy followed by an investigational preoperative chemoimmunotherapy regimen (mFOLFOX6 and nivolumab). On d...

Full description

Bibliographic Details
Main Authors: Aaron Sulkes, Yulia Kundel, Eran Sadot, Pierre Singer, Victoria Neiman, Liudmila Fridel, Marva Harpak, Hanoch Kashtan, Baruch Brenner
Format: Article
Language:English
Published: Elsevier 2020-12-01
Series:Current Problems in Cancer: Case Reports
Subjects:
Locally advanced rectal cancer
Chemoradiotherapy
FOLFOX chemotherapy
Nivolumab
Retroperitoneal and mesenteric serositis
Online Access:http://www.sciencedirect.com/science/article/pii/S2666621920300181

Internet

http://www.sciencedirect.com/science/article/pii/S2666621920300181

Similar Items